Morita therapy for schizophrenia

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2007, Pages

  He, Yanling ^a   Li, C ^b  

^a SHANGHAI MENTAL HEALTH CENTER   (China)

^b NONE

Author keywords

Activities of daily living; Anxiety disorders *therapy ; Bed rest methods ; Culture; Humans; Randomized controlled trials as topic; Schizophrenia *therapy ; Schizophrenic psychology; Socioenvironmental therapy *methods ; Work

Indexed keywords

BEHAVIOR THERAPY; CLINICAL TRIAL; DAILY LIFE ACTIVITY; FAMILY THERAPY; FEASIBILITY STUDY; HUMAN; MENTAL HEALTH; MORITA THERAPY; PSYCHOANALYSIS; PSYCHODYNAMICS; PSYCHOSIS; RANDOMIZATION; REVIEW; SAFETY; SCHIZOPHRENIA; SOCIAL STATUS; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 44949128173     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006346     Document Type: Review

References (58)

1. Cao 2003 {published data only} Cao HJ, Wang SH, You HF, Fan FL, Zhang J. Comparative study of new morita therapy and rehabilitation therapy on recovery of schizophrenia. Modern Journal of Integrated Traditional Chinese and Western Medicine 2003;12(21):2270-2.
2. Chen 1999 {published data only} Chen SQ. The therapeutic effect of morita therapy for schizophrenia patients in recovery period. Sichuan Mental Health 1999;12(4):237-9.
3. Lu 1999 {published data only} Lu Y, Tian M, Zhang Q. A clinical study on effects of neo morita therapy in the treatment of schizophrenia. Chinese Journal of Behavioral Medical Science 1999;8(4):286-8.
4. Lv 2002 {published data only} Lv JJ, Chu YZ, Bai YG, Lv FQ, Lu DZ. The rehabilitative effects of Morita therapy for chronic schizophrenia [Figure 03]. Chinese Journal Nervous and Mental Diseases 2002;28(2):122-4.
5. Tang 2002 {published data only} Tang W, Wang Z. Modified morita therapy for rehabilitation of schizophrenia in comparison with rehabilitation therapy. Shanghai Archives of Psychiatry 2002;14(2):88-90, 93.
6. Tang W, Wang Z. Modifiedmorita therapy on schizophrenic patients. 12th World Congress of Psychiatry; 2002 Aug 24-29; Yokohama, Japan. 2002.
7. Wang 1994 {published data only} Wang X, Ma W, Sun H. Controlled study of modifiedmorita therapy for chronic schizophrenia. Chinese Journal of Health Psychology 2004;12(4):253-6.
8. Wang XY, Ma WY, Sun HX, Jiang T, Lu QZ, Zhang XF, Li Y, Lan B. Comparison of bone mineral density among chromic schizophrenia patients before and after Morita therapy [Figure 07]. Chinese Journal of Osteoporosis 1996;2(4):55-8.
9. Wang XY, Sun HX, Lu QZ, Ma WY, Zhang SH, An JR, Li CL, Han SM, Zhang BT, Li ZT. The application of Morita therapy in chronic schizophrenia [Figure 08]. Health Psychology Journal 1994;2 (1):47-50.
10. Wang 2000 {published data only} Liu CX, Wang RJ, Sun XH. Morita therapy in treatment of inpatients with schizophrenia- MMPI analysis [Figure 05]. Chinese Journal of Behavioral Science 2001;10(1):51.
11. Wang RJ. Morita therapy in treatment of 33 inpatients with schizophrenia- personality analysis [Figure 06]. Nervous diseases and Mental Health 2005;5(6):439-40.
12. Wang RJ, Yuan LL. Morita therapy in treatment of inpatients with schizophrenia. Chinese Mental Health Journal 2000;14(6):404-6.
13. Wang 2002 {published data only} Wang J, Guan T, Xue CY, Fu XQ, Qi JR, Liu JY, Liu GD. A control study on modified Morita therapy for rehabilitation of chronic schizophrenia [Figure 04]. Chinese Journal of Clinical Rehabilitation 2002;6(9):1322-3.
14. Wei 2005 {published data only} Wei Q. Effect of new Morita therapy plus antipsychotic drugs in ameliorating post-schizophrenia depression. Zhongguo Linchuang Kangfu 2005;9(32):72-5.
15. Wu 1999 {published data only} Wu H, Wang Z, Zhang H. Morita therapy in treatment of schizophrenia. Shanghai Archives of Psychiatry 1999;11(12):84-87.
16. Zhu 2002 {published data only} Zhu L, Lu W, Yi Z, Long B, Zhu YH, Fei M. Influence of morita therapy on quality of life in schizophrenic patients. Journal of Clinical Psychological Medicine 2002;12(5): 273-4.
17. Zhu L, Wu G, Long B, Yi ZH, Zhu YH, Fei M. Morita therapy affecting factors of quality of life in long-term in-patients with schizophrenia. Sichuan Mental Health 2002;15(3):151-3.
18. Ma 2000 Ma WY, Wang XY, Sun HX, Zhang SH, Han SM. Clinical observation of Morita therapy 'bed-stage' for chronic schizophrenia [Figure 09]. Journal of Clinical Psychological Medicine 2000;10(1):59.
19. Wang 1998 Wang XY. Morita therapy for the rehabilitation of chronic schizophrenia [Figure 10]. Health Psychology Journal 1998;6(2):199.
20. Wang 2003 Wang WL. Add on Morita therapy for chronic schizophrenia [Figure 13]. Occupation and Health 2003;19(3):108-09.
21. Yue 2002 Yue Y, Song LS, Chen Y. A comparison study of modified Morita therapy with rehabilitation therapy for schizophrenia inpatients [Figure 11]. Chinese Journal of Clinical Rehabilitation 2002;6(13):1956.
22. Zhou 2001 Zhou YL, Han LX, Hou LP, Lu S, Chang AG. The application of modified Morita therapy among 69 cases with schizophrenia at stable stage [Figure 12]. Medical Journal of the Chinese People's Armed Police Forces 2001;12(4):228-9.
23. Altman 1996 Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313:1200.
24. Andreasen 1983 Andreasen NC. Negative symptoms in schizophrenia. Archives of General Psychiatry 1983;39:784-8.
25. Bland 1997 Bland JM, Kerry SM. Statistics notes. Trials randomised in clusters. BMJ 1997;315:600.
26. Boissel 1999 Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M, Boutitie F, Nony P, Haugh M, Mignot G. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use. Therapie 1999;54(4):405-11.
27. Buckley 2006 Buckley LA, Pettit T. Supportive therapy for schizophrenia. Cochrane Database of Systematic Reviews 2006, Issue 1.Art. No.: CD004716. DOI:10.1002/14651858.CD004716.pub3.
28. Catty 2006 Catty J, Burns T, Comas A, Bunstead Z. Day centres for severe mental illness. Cochrane Database of Systematic Reviews 2006, Issue 1.Art. No.: CD001710. DOI:10.1002/14651858.CD001710.pub2.
29. Chen 1995 Chen P, Yu ES, Zhang M, Liu WT, Hill R, Katzman R. ADL Dependence and Medical Conditions in Chinese older persons: A population - Based survey in Shanghai, China. Journal of American Geriatric Society 1995;43(4):378-83.
30. Chilvers 2006 Chilvers R, Macdonald GM, Hayes AA. Supported housing for people with severe mental disorders. Cochrane Database of Systematic Reviews 2006, Issue 4.Art. No.: CD000453. DOI: 10.1002/14651858.CD000453.pub2.
31. Cormac 2004 Cormac I, Jones C, Campbell C. Cognitive behaviour therapy for schizophrenia. Cochrane Database of Systematic Reviews 2004, Issue 4.Art. No.: CD000524. DOI:10.1002/14651858.CD000524.pub2.
32. Deeks 2002 Deeks JJ. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes Issues in the selection of a summary statistic for meta-analysis of clinical trials with. Statistical Medicine 2002;21:1575-1600.
33. Divine 1992 Divine GW, Brown JT, Frazer LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7:623-9.
34. DoH 2001 Department of Health. Treatment choice in psychological therapies and counselling evidence based clinical practice guideline. London: Department of Health, 2001.
35. Egger 1997 Egger M, Davey-Smith G, Schneider M, Minder CSO. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;13:629-34.
36. Gulliford 1999 Gulliford MC, Ukoumunne OC, Chinn S. Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149:876-83.
37. Hamilton 1960 Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry 1960;23:56-62.
38. Higgins 2003 Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
39. Higgins 2005 Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. The Cochrane Library 2005, issue Issue 3.
40. Honigfeld 1965 Honigfeld G, Klett C J. The Nurses' Observation Scale for Inpatient Evaluation: A new scale for measuring improvement in chronic schizophrenia. Journal of Clinical Psychology 1965;21:65-71.
41. Jones 2004 C Jones, I Cormac, JI Silveira da Mota Neto, C Campbell. Cognitive behaviour therapy for schizophrenia. Cochrane Database of Systematic Reviews 2004, Issue 4.Art. No.: CD000524. DOI: 10.1002/14651858.CD000524.pub2.
42. Juni 2001 Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. British Medical Journal 2001;323:42-6.
43. Li 1994 Li G, Hu X, Jin D, Tian W, Phillips MR. A rating instrument for the evaluation of in-patient rehabilitation programmes in China. Results of reliability and validity testing. British Journal of Psychiatry 1994; Suppl.(24):58-65.
44. Lu 1995 Lu YZ, Tiandai Xinxiong. A brief introduction of the research advance of Morita therapy for schizophrenia in Japan [translated details - see Figure 02] [Figure 02]. Chinese Mental Health Journal 1995;9(6):271-3.
45. Marshall 2000 Marshall M, Lockwood A, Bradley C, Adams C, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249-52.
46. McIntosh 2006 McIntosh AM, Conlon L, Lawrie SM, Stanfield AC. Compliance therapy for schizophrenia. Cochrane Database of Systematic Reviews 2006, Issue 3.Art. No.: CD003442. DOI: 10.1002/14651858.CD003442. pub2.
47. Moher 2001 Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001;285:1987-91.
48. NICE 2003 National Institute for Clinical Excellence. Schizophrenia. Full national clinical guideline on core interventions in primary and secondary care. London: Gaskell, 2003.
49. NIMH 1985 National Institute of Mental Health. Treatment Emergent Symptoms Scale - write-in (TESS). Psychopharmacological Bulletin 1985;21:1069-73.
50. Overall 1962 Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychological Report 1962;10:799-812.
51. Pekkala 2002 Pekkala E, Merinder L. Psychoeducation for schizophrenia. Cochrane Database of Systematic Reviews 2002, Issue 2.Art. No.: CD002831. DOI:10.1002/14651858.CD002831.
52. Pharoah 2006 Pharoah FM, Rathbone J, Mari JJ, Streiner D. Family intervention for schizophrenia. Cochrane Database of Systematic Reviews 2006, Issue 4.Art. No.: CD000088. DOI:10.1002/14651858.CD000088.pub2.
53. Reynolds 1980 Reynolds DK, Keifer CW. Cultural adaptability as an attribute of therapies: the case of morita psychotherapy. Culture, Medicine and Psychiatry 1980;1 (4):395-412.
54. Shen 1985 Shen Y, Wang, C. A Handbook of Epidemiological Investigation of Mental Illness. Beijing: Renming Health Press, 1985.
55. Song 1996 Song LS, Zhang MY, Wu HM. Themeasurement and testing of quality of life scale for community psychotic patients. Shanghai Archive of Psychiatry 1996;8(4):255-7.
56. Suzuki 1989 Suzuki T. The concept of neurasthenia and its treatment in Japan. Culture, Medicine and Psychiatry 1989;13 (2):187-202.
57. Takeda 1964 Takeda K. Morita therapy. Journal of Religion and Health 1964;3:335-44.
58. Wen 2001 Wen QR. Development of Morita therapy in China. Health Psychology Journal 2001;9(3):233-5.